Amalgamated Bank’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.66M | Sell |
15,577
-344
| -2% | -$41.7K | 0.01% | 919 |
|
|
2026
Q1 | $2.6M | Sell |
15,921
-822
| -5% | -$126K | 0.02% | 689 |
|
|
2025
Q4 | $2.91M | Buy |
16,743
+2,210
| +15% | +$403K | 0.02% | 643 |
|
|
2025
Q3 | $2.09M | Buy |
14,533
+1,560
| +12% | +$191K | 0.02% | 800 |
|
|
2025
Q2 | $1.31M | Buy |
12,973
+7,003
| +117% | +$535K | 0.01% | 947 |
|
|
2025
Q1 | $455K | Buy |
5,970
+91
| +2% | +$6.96K | ﹤0.01% | 1298 |
|
|
2024
Q4 | $406K | Buy |
5,879
+552
| +10% | +$39.8K | ﹤0.01% | 1367 |
|
|
2024
Q3 | $389K | Hold |
5,327
| – | – | ﹤0.01% | 1394 |
|
|
2024
Q2 | $357K | Buy |
5,327
+701
| +15% | +$27.2K | ﹤0.01% | 1420 |
|
|
2024
Q1 | $126K | Sell |
4,626
-15,138
| -77% | -$424K | ﹤0.01% | 1685 |
|
|
2023
Q4 | $612K | Sell |
19,764
-679
| -3% | -$17.6K | ﹤0.01% | 1360 |
|
|
2023
Q3 | $516K | Buy |
20,443
+222
| +1% | +$5.08K | ﹤0.01% | 1392 |
|
|
2023
Q2 | $427K | Buy |
20,221
+1,117
| +6% | +$21.2K | ﹤0.01% | 1513 |
|
|
2023
Q1 | $326K | Sell |
19,104
-3,207
| -14% | -$62.3K | ﹤0.01% | 1603 |
|
|
2022
Q4 | $446K | Buy |
22,311
+3,119
| +16% | +$60.3K | ﹤0.01% | 1512 |
|
|
2022
Q3 | $413K | Buy |
19,192
+306
| +2% | +$7.34K | ﹤0.01% | 1525 |
|
|
2022
Q2 | $372K | Sell |
18,886
-447
| -2% | -$9.37K | ﹤0.01% | 1612 |
|
|
2022
Q1 | $454K | Sell |
19,333
-1,284
| -6% | -$29.8K | ﹤0.01% | 1590 |
|
|
2021
Q4 | $562K | Buy |
20,617
+182
| +0.9% | +$5.2K | ﹤0.01% | 1522 |
|
|
2021
Q3 | $563K | Buy |
20,435
+936
| +5% | +$24.6K | ﹤0.01% | 1513 |
|
|
2021
Q2 | $555K | Buy |
19,499
+5,085
| +35% | +$151K | ﹤0.01% | 1589 |
|
|
2021
Q1 | $491K | Sell |
14,414
-1,409
| -9% | -$53.8K | 0.02% | 990 |
|
|
2020
Q4 | $527K | Buy |
15,823
+84
| +0.5% | +$3.07K | 0.02% | 937 |
|
|
2020
Q3 | $506K | Sell |
15,739
-462
| -3% | -$13.3K | 0.02% | 825 |
|
|
2020
Q2 | $446K | Buy |
16,201
+360
| +2% | +$8.53K | 0.02% | 895 |
|
|
2020
Q1 | $254K | Sell |
15,841
-404
| -2% | -$9.58K | 0.01% | 1229 |
|
|
2019
Q4 | $388K | Buy |
16,245
+2,491
| +18% | +$50.7K | 0.01% | 1255 |
|
|
2019
Q3 | $243K | Sell |
13,754
-181
| -1% | -$3.5K | 0.01% | 1444 |
|
|
2019
Q2 | $357K | Buy |
13,935
+2,083
| +18% | +$58K | 0.01% | 1250 |
|
|
2019
Q1 | $345K | Buy |
11,852
+307
| +3% | +$7.96K | 0.01% | 1181 |
|
|
2018
Q4 | $151K | Buy |
+11,545
| New | +$184K | ﹤0.01% | 1463 |
|
|
2018
Q3 | – | Sell |
-11,699
| Closed | -$277K | – | 1530 |
|
|
2018
Q2 | $277K | Buy |
11,699
+1,518
| +15% | +$39.1K | 0.01% | 1367 |
|
|
2018
Q1 | $229K | Sell |
10,181
-221
| -2% | -$5.82K | 0.01% | 1377 |
|
|
2017
Q4 | $324K | Buy |
10,402
+971
| +10% | +$28.7K | 0.01% | 1226 |
|
|
2017
Q3 | $294K | Buy |
+9,431
| New | +$180K | 0.01% | 1225 |
|
Other funds holding INSM
TCM
Amalgamated Bank's INSM Position: Q2 2026 in Review
Amalgamated Bank reduced its Insmed (INSM) stake by 2.2% in Q2 2026, selling an estimated $41.7K and leaving 15,577 shares worth $1.66M. The position accounts for 0.01% of the portfolio, ranked #919.
Amalgamated Bank first reported a position in INSM in Q3 2017 and has held it in 35 quarters since. The position peaked at $2.91M in Q4 2025. 291 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Amalgamated Bank held 15,577 shares of Insmed worth $1.66M as of Q2 2026.
- Amalgamated Bank sold 344 Insmed shares in Q2 2026, an estimated $41.7K.
- Insmed made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #919 holding.
- Amalgamated Bank first reported a position in Insmed in Q3 2017 and has held it in 35 quarters since.
- Amalgamated Bank's Insmed position peaked at $2.91M in Q4 2025.
- 291 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.